XML 21 R15.htm IDEA: XBRL DOCUMENT
v3.25.3

NET EARNINGS PER SHARE AND SHARE REPURCHASES | 9 Months Ended
--- | ---
Sep. 30, 2025
Earnings Per Share [Abstract] |
NET EARNINGS PER SHARE AND SHARE REPURCHASES | NOTE 4: NET EARNINGS PER SHARE AND SHARE REPURCHASES Our basic and diluted earnings per share were: ● $0.11 during third quarter 2025 and $0.35 during year-to-date 2 025; ● $0.04 during third quarter 2024 and $0.43 during year-to-date 2024. Basic earnings per share is net earnings divided by the weighted average number of our outstanding common shares, including stock equivalent units where there is no circumstance under which those shares would not be issued. Diluted earnings per share is net earnings divided by the sum of the weighted average number of our outstanding common shares and the effect of our outstanding dilutive potential common shares.
|  | QUARTER ENDED |  |  | YEAR-TO-DATE ENDED |
SHARES IN THOUSANDS |  | SEPTEMBER 2025 |  |  | SEPTEMBER 2024 |  |  | SEPTEMBER 2025 |  |  | SEPTEMBER 2024 |
Weighted average common shares outstanding – basic |  |  | 721,598 |  |  |  | 727,621 |  |  |  | 723,791 |  |  |  | 728,892 |
Dilutive potential common shares: |  |  |  |  |  |  |  |  |  |  |  |
Stock options |  |  | 28 |  |  |  | 95 |  |  |  | 46 |  |  |  | 115 |
Restricted stock units |  |  | 231 |  |  |  | 329 |  |  |  | 105 |  |  |  | 203 |
Performance share units |  |  | 155 |  |  |  | 135 |  |  |  | 209 |  |  |  | 145 |
Total effect of outstanding dilutive potential common shares |  |  | 414 |  |  |  | 559 |  |  |  | 360 |  |  |  | 463 |
Weighted average common shares outstanding – dilutive |  |  | 722,012 |  |  |  | 728,180 |  |  |  | 724,151 |  |  |  | 729,355 |
We use the treasury stock method to calculate the dilutive effect of our outstanding stock options, restricted stock units and performance share units. Potential Shares Not Included in the Computation of Diluted Earnings per Share The following shares were not included in the computation of diluted earnings per share because they were either antidilutive or the required performance or market conditions were not met. Some or all of these shares may be dilutive potential common shares in future periods.
|  | QUARTER ENDED |  |  | YEAR-TO-DATE ENDED |
SHARES IN THOUSANDS |  | SEPTEMBER 2025 |  |  | SEPTEMBER 2024 |  |  | SEPTEMBER 2025 |  |  | SEPTEMBER 2024 |
Stock options |  |  | — |  |  |  | 607 |  |  |  | — |  |  |  | 607 |
Performance share units |  |  | 1,028 |  |  |  | 892 |  |  |  | 1,028 |  |  |  | 892 |
Share Repurchase Program During second quarter 2025, we completed the $1 billion purchase authorization under the share repurchase program approved by the board in September 2021 (the 2021 Repurchase Program). On May 8, 2025, we announced the board approved a new share repurchase program (the 2025 Repurchase Program) under which we are authorized to repurchase up to $1 billion of outstanding shares. Concurrently, the board of directors terminated the completed purchase authorization under the 2021 Repurchase Program. We repurchased 980,114 common shares for approximately $25 million (including transaction fees) under the 2025 Repurchase Program during third quarter 2025 and 5,714,095 common shares for approximately $150 million (including transaction fees) under the share repurchase programs during year-to-date 2025. As of September 30, 2025, we had remaining authorization of $948 million for future share repurchases under the 2025 Repurchase Program. During third quarter 2024, we repurchased 820,706 common shares for approximately $26 million (including transaction fees) and 3,962,220 common shares for approximately $125 million (including transaction fees) during year-to-date 2024 under the 2021 Repurchase Program. All common stock repurchases under the share repurchase programs were made in open-market transactions. We record share repurchases upon trade date as opposed to the settlement date when cash is disbursed. We record a liability for repurchases that have not yet been settled as of period end. There were no unsettled shares as of September 30, 2025 and 12,436 unsettl ed shares (less than $1 million) as of December 31, 2024.

X
- References No definition available. + Details
Name: | us-gaap_EarningsPerShareAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration

X
- Definition The entire disclosure for earnings per share. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 1 -Subparagraph (c) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-1 Reference 2: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -Name Accounting Standards Codification -Publisher FASB -URI https://asc.fasb.org/260/tableOfContent Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-2 Reference 4: http://www.xbrl.org/2003/role/disclosureRef -Topic 260 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482662/260-10-50-3 + Details
Name: | us-gaap_EarningsPerShareTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration